Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension
Ricardo Mastaï, Bernard Rocheleau, P. ‐Michel Huet – 1 February 1989 – It has recently been reported that the administration of ketanserin, a serotonin antagonist, was associated with a significant reduction in portal pressure both in portal hypertensive rats and cirrhotic patients. However, this beneficial effect on splanchnic hemodynamics was accompanied by a significant reduction in arterial pressure.